Oliver James Hulme serves as Associate Professor in the Department of Psychology within the Faculty of Social Sciences at the University of Copenhagen. His office is located at Øster Farimagsgade 2A, 1350 København K, with scheduled office hours on Thursdays from 12:00-13:00. His research focuses on: Reward decision-making risk-taking neuroeconomics functional neuroimaging Bayesian modelling cognitive computational neuroscience open science Publications from 2013-2024 demonstrate sustained investigation into neural mechanisms of decision processes, particularly in Parkinson's disease, aging populations, and eating disorders. His methodology integrates fMRI, computational modeling, and behavioral paradigms to examine risk assessment, neural connectivity, and cognitive control under varying physiological states. No scientific awards were documented in the source material. Details regarding student supervision, grant funding, and laboratory infrastructure were not provided in the available information.
Krisztina Benedek serves as a Guest Researcher at the Department of Neuroscience within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research focuses on unraveling the complex relationship between brain aging, vascular function, and cognitive performance through rigorous scientific investigation. Dr. Benedek's primary research interests encompass cognitive neuroscience with special emphasis on aging-related changes in brain structure and function. Her work investigates cerebral blood flow dynamics, amyloid accumulation patterns, and neural oscillatory activity in relation to cognitive performance across the lifespan. Using advanced neuroimaging techniques including fMRI and PET, as well as electrophysiological measurements, she examines early markers of cognitive decline in aging populations, particularly focusing on the longitudinal Metropolit 1953 Danish male cohort. Her research program spans multiple methodologies to investigate how subtle changes in cerebrovascular responses, amyloid deposition, and neural network activity correlate with cognitive function before significant structural brain changes occur. Analysis of her publication record reveals a consistent research trajectory examining the early neural correlates of cognitive aging. Her most recent work (2024-2025) focuses on identifying biomarkers of preclinical cognitive decline, while her earlier publications established her interest in electrophysiological markers of brain aging, particularly regarding visual processing and gamma oscillatory activity. The publications demonstrate collaborative work with leading researchers in the field and appear in reputable journals such as GeroScience, Alzheimer's Research and Therapy, and PLOS ONE.
Kayeon Kim serves as Assistant Professor in the Department of Neuroscience at the University of Copenhagen's Faculty of Health and Medical Sciences, where she leads the Neuronal Signalling research group. Her work bridges fundamental neuroscience and neuroengineering to investigate brain function and dysfunction. Her research spans neuronal communication at single-cell and circuit levels, neurovascular coupling mechanisms, hippocampal network dynamics during memory processes, and development of precision neuromodulation technologies. Key focus areas include: Micro-coil based neural stimulation for seizure control Spatiotemporal relationships between blood flow and neural activity Neurovascular alterations in aging and disease Hippocampal oscillation patterns in learning and memory consolidation Analysis of her 2023-2025 publications reveals a cohesive research trajectory integrating engineering solutions with neuroscience questions. Her work consistently addresses translational challenges in epilepsy treatment and age-related cognitive decline through innovative methodologies like intracortical microstimulation and MEMS device development. Based at Blegdamsvej 3B in Copenhagen, she maintains active collaborations across neuroscience and engineering disciplines as evidenced by multi-institutional publications and international media coverage of her research.
Michael Eriksen Benros is a Clinical Professor at the Department of Clinical Medicine, University of Copenhagen, and heads the Biological and Precision Psychiatry unit at Mental Health Centre Copenhagen, Copenhagen University Hospital. He serves as a board member of the Psychiatric Immunology Section of the World Psychiatric Association and is co-PI on the DanFunD study. Dr. Benros is a leading expert in Immuno-Psychiatry, Biological Psychiatry, Epidemiology, and Precision Psychiatry. His research focuses on the intersection of immune-related factors and mental illness, utilizing Danish nationwide registers, biobanks, and clinical studies. He leads significant efforts to understand the role of the immune system in severe mental disorders through immunogenetic investigations and novel research on cerebrospinal fluid and blood samples from patients with psychotic and affective disorders. His most recent publications (2025) demonstrate a continued focus on neuroimmunology, with studies examining the neurological impacts of COVID-19, perinatal immune markers and ADHD, genetic prediction methods, and lifestyle factors in functional somatic disorders. Earlier landmark publications (2020) established foundational work in autoimmune psychosis and the mental health consequences of the pandemic. His scientific recognition includes: Sapere Aude Research Leader award from the Independent Research Fond Denmark Dr. Benros has secured substantial research funding for his work on immuno-psychiatry and precision psychiatry, including leadership of the Precision Psychiatry Initiative which utilizes systems biology and machine learning methods to develop more precise diagnostics and identify new treatment targets. His research leverages Denmark's unique nationwide registers and biobanks to investigate immune exposures in relation to mental disorders. He directs a significant research group focused on Biological and Precision Psychiatry at Mental Health Centre Copenhagen, where they combine register data with immunogenetic investigations and novel research on cerebrospinal fluid and blood from clinical studies. His team employs omics and systems biology approaches to unravel the complex relationship between the immune system and mental health.
Ida Egmose Pedersen is a Tenure Track Assistant Professor in the Department of Psychology at the Faculty of Social Sciences, University of Copenhagen. Her research focuses on early intervention, parent-child interaction, attachment, and parental competence, particularly in the context of first-time parenthood and infant development. Education: 2018-2022: Postdoc, Center for Early Intervention and Family Studies, Department of Psychology, University of Copenhagen 2015-2018: PhD, Babylab, Department of Psychology, University of Copenhagen 2014-2015: M.Sc. in Psychology, University of Copenhagen 2010-2014: B.Sc. in Psychology, University of Copenhagen Dr. Pedersen's research centers on early intervention programs for parents, such as the "Understanding Your Baby" project (2019-2022), which developed a research-based intervention for first-time parents delivered by health nurses. Her work explores parental competence, infant social and emotional needs, screen use, and attachment. She investigates how parental reflective functioning and mind-mindedness influence parenting behaviors and child outcomes. Her recent publications (2024-2025) demonstrate a strong focus on developing and evaluating interventions for parents and caregivers, validating assessment tools for parental functioning, and studying the impact of maternal mental health on infant development. Key themes include early intervention, parent-child interaction, and attachment. Scientific Awards: No scientific awards are mentioned in the provided text. Grants and Advising: Dr. Pedersen is the principal investigator for the "Understanding Your Baby" project, funded by the Nordea Foundation (10,200,000 DKK). This project examines parental well-being and the efficacy of an intervention to enhance parental competence. While the text does not list specific advisees, her role as a Tenure Track Assistant Professor likely involves mentoring graduate students. She collaborates extensively with Danish municipalities and research teams on early childhood interventions. Labs and Teams: Dr. Pedersen is affiliated with the Center for Early Intervention and Family Studies at the University of Copenhagen. She leads the "Understanding Your Baby" project in collaboration with Danish municipalities and has been involved in the Copenhagen Daycare Project. Her research network includes collaborations with institutions such as The Institute for Intelligent Systems and Robotics (ISIR) at Pierre-and-Marie-Curie University (UPMC) during a visiting period in 2017.
Louise Saviø Piilgaard is a Guest Researcher in the Neuronal Signalling research group within the Department of Neuroscience at the University of Copenhagen's Faculty of Health and Medical Sciences. Her research is conducted at the Blegdamsvej 3 campus in Copenhagen. Dr. Piilgaard's research focuses on the intersection of sleep medicine, electrophysiology, and neurological disorders, with particular expertise in narcolepsy research. Her work heavily utilizes mouse models to investigate sleep-wake dynamics, EEG patterns, and neurological mechanisms underlying sleep disorders. She has made significant contributions to understanding narcolepsy type 1 through innovative approaches to EEG and EMG data analysis, as well as developing non-invasive monitoring techniques for disease progression. Analysis of her publication record from 2019-2025 reveals a strong focus on narcolepsy research, particularly using mouse models to investigate disease mechanisms. Her work spans multiple approaches including electrophysiological analysis, behavioral monitoring, and pharmacological investigations. A notable trend is her progression from basic receptor pharmacology studies toward more complex disease modeling and machine learning applications for disease prediction. Dr. Piilgaard has established productive collaborations with researchers across multiple institutions, as evidenced by her co-authorship on publications with diverse research teams. Her work has received attention across academic platforms, with multiple publications highlighted on social media and research-sharing sites.
Katrine Laura Rasmussen is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her work spans both Clinical Biochemistry and medical research with dual institutional affiliations at Dyrehavevej 29, 3400 Hillerød and Blegdamsvej 3, 2200 København N. Her research interests focus on the intersection of genetics, neurodegenerative disorders, and cardiovascular disease, with particular expertise in apolipoprotein E (APOE) research. Dr. Rasmussen's work explores genetic risk factors for Alzheimer's disease, cardiovascular conditions, and their interrelationships, contributing significantly to understanding disease mechanisms and risk prediction. Analysis of her recent publications reveals a strong emphasis on population-based genetic studies, risk assessment methodologies, and translational research connecting laboratory findings with clinical applications. Her work frequently appears in high-impact journals across neurology, cardiology, and genetics disciplines, demonstrating interdisciplinary collaboration across international research teams. Dr. Rasmussen has received significant research attention, with her work being picked up by numerous news outlets and shared extensively across academic social media platforms. Several of her publications have garnered substantial attention on Mendeley, indicating their importance to the research community.
Peter Lommer Kristensen serves as a Clinical Associate Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. His dual institutional affiliations include locations in both Hillerød (Dyrehavevej 29) and Copenhagen (Blegdamsvej 3), reflecting his integration between academic research and clinical practice through Region Hovedstaden healthcare services. His research expertise focuses on diabetes management with particular emphasis on: Hypoglycemia effects on cognitive and cardiac function Continuous Glucose Monitoring systems implementation Inpatient diabetes care protocols Insulin therapy optimization Clinical trial methodology in diabetes research Dr. Kristensen's 2025 publications reveal a concentrated research program examining hypoglycemia mechanisms, technology-enhanced diabetes management, and evidence-based protocols for hospital settings. His work frequently involves large-scale clinical trials like the Hypo-RESOLVE study and demonstrates strong collaborative networks across European institutions. His research has gained significant academic traction with multiple Scopus citations and substantial engagement on platforms like Mendeley, with several papers receiving attention from news outlets and social media discussions. The DIATEC randomized controlled trial represents a major contribution to evidence-based inpatient diabetes management. As a Clinical Research Lecturer ( Klinisk forskningslektor ) in Endocrinology, he bridges clinical practice with academic research, focusing on practical applications that improve diabetes outcomes in real-world settings.
Clinical Associate Professor Vibeke Renée Lind Jørgensen is affiliated with the Department of Clinical Medicine, Anaesthesiology at the University of Copenhagen's Faculty of Health and Medical Sciences. She maintains active clinical and research roles in intensive care medicine with a focus on critical care outcomes and management. Her research interests center on critical care medicine with specific expertise in management of cardiac arrest patients, blood pressure optimization in intensive care, and long-term outcomes following critical illness. Her work particularly focuses on COVID-19 patients in intensive care settings, examining thromboembolic complications, superinfections, and cognitive recovery trajectories. She has contributed significantly to understanding optimal blood pressure targets in post-cardiac arrest care through the BOX trial analysis. Her publications demonstrate strong collaborative work with Danish intensive care units and national registries, showing a pattern of high-impact research published in leading anesthesia and critical care journals including New England Journal of Medicine and Acta Anaesthesiologica Scandinavica. Her research has been widely disseminated, with multiple studies highlighted by news outlets, referenced in clinical guidelines, and generating significant academic discussion on platforms like Mendeley. Professor Jørgensen works within the broader Danish critical care research network, contributing to national observational studies and clinical trials that inform ICU practice across Denmark. Her work bridges clinical practice with rigorous outcomes research, particularly focusing on post-intensive care recovery and specialized management of complex critical care scenarios.
Maj Vinberg is a Clinical Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, specializing in Psychiatry. Based at Blegdamsvej 3, 2200 Copenhagen N, Denmark, she holds an ORCID (0000-0002-5982-1335) and maintains clinical-academic roles with Region Hovedstaden (email: maj.vinberg@regionh.dk, phone: +4538643227). Her educational qualifications include: MD DMSc PhD Vinberg's research centers on mood disorders through longitudinal twin studies investigating cognitive predictors, biomarkers, and treatment outcomes. Key interests include bipolar disorder pathophysiology, cognitive functioning in affective episodes, pharmacovigilance of antidepressants, and virtual reality assessment tools. Her work integrates genetic vulnerability with environmental factors like lifestyle and metabolic health. Analysis of her 2025 publications reveals dominant themes: 1) Twin-based prediction models for mood disorder onset/recurrence using cognitive and personality metrics; 2) Neuroimaging and biomarker studies (e.g., erythropoietin effects on brain structure, malondialdehyde as oxidative stress marker); 3) Pharmacovigilance investigations linking antidepressants to ocular complications; 4) Digital phenotyping via virtual reality for functional assessment. Scientific recognition: No awards explicitly documented in source material Collaborative networks with Kessing, Miskowiak, and Nordentoft drive her research program, though specific grant details and advised students aren't disclosed in available information. Her departmental affiliation indicates integration within Copenhagen's psychiatric research infrastructure.
Mikkel Vestergaard serves as an Assistant Professor in the Department of Neuroscience within the Faculty of Health and Medical Sciences at the University of Copenhagen, specializing in Systems Neuroscience research and teaching activities. His primary research domain focuses on Systems Neuroscience, investigating neural circuit mechanisms underlying cognitive processes and behavior. This discipline integrates experimental neurophysiology with computational modeling to decode brain function at the network level, emphasizing translational applications for understanding neurological disorders. Dr. Vestergaard maintains active academic engagement through departmental responsibilities at the University of Copenhagen's neuroscience hub. While specific advising roles and research grants remain undocumented in the source material, his position inherently involves supervising graduate students and contributing to institutional research initiatives within the neuroscience community.
Mikkel Vass serves as a Senior Researcher at the Research Unit for General Practice (Forskningsenheden for Almen Praksis) within the Center for Health and Society at the University of Copenhagen's School of Health and Medical Sciences. His work focuses on geriatric medicine and public health issues affecting elderly populations in Denmark. Dr. Vass's primary research interests include: Dementia and its implications for daily functioning, particularly regarding traffic safety Frailty assessment and definition in elderly care Socioeconomic determinants of health outcomes in aging populations Effectiveness of interventions for elderly patients, including home visits after hospital discharge Mobility issues and functional decline in old age Analysis of his publication record (2014-2019) reveals a strong emphasis on register-based epidemiological studies leveraging Denmark's comprehensive health registries. A notable trend shows increasing focus on the intersection of cognitive impairment (particularly dementia) with practical aspects of daily living such as driving safety. His methodological approach frequently addresses confounding factors like socioeconomic position, demonstrating sophisticated epidemiological reasoning in observational research. With 71 documented research outputs including 53 journal articles, 6 book chapters, and 2 books, Dr. Vass has established himself as a productive researcher in geriatric medicine. His work appears in reputable journals such as Scandinavian Journal of Public Health, Pharmacoepidemiology and Drug Safety, and BMJ Open, indicating recognition within the scientific community. Dr. Vass collaborates extensively with researchers including V. D. Siersma, C. Hendriksen, and F. B. Waldorff, suggesting well-established research partnerships focused on aging and primary care. His research unit appears to focus on general practice with particular attention to elderly populations, aligning with his research interests in community-based care for aging individuals.
Maurice Ptito serves as a Guest Researcher in the Department of Neuroscience within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research primarily investigates neural adaptations following sensory deprivation, with particular emphasis on visual system plasticity in blindness. His research interests span multiple interconnected domains of neuroscience: Structural and functional brain reorganization in sensory loss Development and application of visual prosthetic technologies Cognitive mapping and spatial navigation mechanisms in blindness Retinal function and neuropharmacology using primate models Translational applications of neuroplasticity findings Analysis of his recent publications reveals a strong focus on cross-modal plasticity, with significant contributions to understanding how the brain compensates for visual deprivation through tactile and auditory substitution. His work increasingly integrates artificial intelligence with neural engineering approaches for visual restoration. Current research trends show expansion into neuropharmacological interventions for addiction using primate models, while maintaining core investigations into structural brain changes documented through advanced neuroimaging techniques. His scientific impact is evidenced by substantial citation metrics across recent publications, with notable attention from news outlets and academic platforms. Collaborative networks span international institutions focused on sensory neuroscience and rehabilitation. Ptito maintains active research supervision and contributes to academic discourse through editorial leadership in specialized neuroscience journals. His laboratory work involves both human participants with visual impairments and non-human primate models for translational studies.
Louise Møller Jørgensen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with research operations closely integrated with the Capital Region of Denmark (Region Hovedstaden) as evidenced by her institutional email domain and collaborative publications. Her research spans Neuroscience, Neuroimaging, and Pain Medicine, focusing on molecular biomarkers for disc degeneration (e.g., cytokines, TRP channels, metalloproteinases), advanced neuroimaging techniques (PET/fMRI), and neurological disorders like Parkinson's disease. She investigates pain mechanisms, surgical outcomes, and cognitive disturbances through translational approaches combining molecular analysis, animal models, and clinical assessments. Analysis of her 2022-2024 publications reveals dominant trends in biomarker discovery for spinal conditions and neurodegenerative diseases, alongside methodological innovations in neuroimaging. Key interdisciplinary themes include PET radioligand development, electrical stimulation systems, and the intersection of molecular biology with clinical pain management. Dr. Jørgensen maintains extensive collaborations across Danish medical institutions, notably with G.M. Knudsen's team, and her work demonstrates significant academic engagement through media coverage (1 news outlet), social media (6 X users), and scholarly platforms (130+ Mendeley readers). While specific grant details and student mentorship aren't documented, her publication volume and co-authorship patterns indicate active leadership in multi-institutional research projects.
Kristian Steen Frederiksen serves as a Clinical Associate Professor at the University of Copenhagen's Department of Clinical Medicine and as a Senior Hospital Physician at Rigshospitalet's Department of Neurology. He is the director of the clinical trial unit at the Danish Dementia Research Centre (DDRC), where he leads drug intervention studies (phase I-IV) and clinical research in Alzheimer's disease, Huntington's disease, and related disorders. His work bridges academic research and clinical practice through a dual appointment with the Capital Region of Denmark and the University of Copenhagen. Dr. Frederiksen's research focuses on neurodegenerative dementia with particular emphasis on Alzheimer's disease and Lewy body dementia. His specific scientific focus includes biomarkers for early diagnostics and as outcome measures in intervention studies, investigation of pathophysiological mechanisms in neurodegenerative diseases, and the development of digital and imaging markers for clinical implementation. His work spans biomarker research, early disease manifestations, clinical applications, and digital innovation in dementia diagnostics. Analysis of his recent publications reveals a strong emphasis on diagnostic innovation, particularly in biomarker development for neurodegenerative diseases. His research integrates traditional biomarker approaches with digital health technologies and machine learning applications. A significant portion of his work addresses the implementation challenges of new therapies, particularly anti-amyloid treatments for Alzheimer's disease, reflecting his active role in European clinical guidelines development. Scientific Awards: Firkløver-fondens Hæderspris for Forskning 2025 (Firkløver Foundation Research Honor Prize) Dr. Frederiksen serves as Editor-in-Chief for Alzheimer's Research & Therapy (since June 2024) and has received substantial research funding from organizations including Alzheimer Forskningsfonden, Parkinsonforeningen, Innovation Fund Denmark, and industry partners. He acts as Principal or Sub-investigator and National Coordinator on multiple industry-sponsored phase 2 and 3 trials for Alzheimer's disease involving companies like Roche, Biogen, Novo Nordisk, and Eisai/Bioarctic. His extensive conflict of interest disclosures reflect his significant involvement in the dementia research ecosystem through editorial roles, advisory boards, and speaking engagements with major pharmaceutical companies. At the Danish Dementia Research Centre, Dr. Frederiksen leads a multidisciplinary team conducting cutting-edge research on dementia diagnostics and therapeutics. His clinical trial unit coordinates international studies while maintaining strong connections with European research networks including the European Alzheimer's Disease Consortium (EADC). His work bridges basic science, clinical application, and healthcare implementation, positioning him at the forefront of dementia research in Europe.
